Pyruvate Decarboxylase DeficiencySymptoms, Doctors, Treatments, Advances & More
Pyruvate Decarboxylase Deficiency Overview
Learn About Pyruvate Decarboxylase Deficiency
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Rosa Ferriero practices practicing medicine in Pozzuoli, Italy. Ms. Ferriero is rated as an Elite expert by MediFind in the treatment of Pyruvate Decarboxylase Deficiency. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Pyruvate Decarboxylase Deficiency, Pyruvate Dehydrogenase Deficiency, Lactic Acidosis, and Maple Syrup Urine Disease.
Nicola Brunetti-Pierri is a Pediatrics specialist and a Medical Genetics provider practicing medicine in Houston, Texas. Dr. Brunetti-Pierri is rated as an Elite provider by MediFind in the treatment of Pyruvate Decarboxylase Deficiency. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Pyruvate Decarboxylase Deficiency, Crigler-Najjar Syndrome, Argininosuccinic Aciduria, and Rotor Syndrome.
Jirair Bedoyan is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Pittsburgh, Pennsylvania. Dr. Bedoyan is rated as an Elite provider by MediFind in the treatment of Pyruvate Decarboxylase Deficiency. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Pyruvate Dehydrogenase Deficiency, Pyruvate Decarboxylase Deficiency, Dihydrolipoamide Dehydrogenase Deficiency, Urea Cycle Disorders (UCD), and Gastrostomy. Dr. Bedoyan is currently accepting new patients.
Summary: This is a phase II, multicenter, prospective, non-comparative clinical trial to assess the efficacy and safety of the treatment of pyruvate dehydrogenase deficiency (PDH) patients with glycerol phenylbutyrate (Ravicti®). The trial will be conducted with three visits: 3 day hospitalizations including clinical consultations and paramedical procedures at Month 0 (M0), Month 3 (M3), Month 6 (M6). Duri...
Summary: This is a medical research study to test a medication in patients with a disease called Pyruvate Dehydrogenase Complex (PDC) Deficiency. The medication is triheptanoin, which is currently FDA approved for the treatment of Long-Chain Fatty Acid Oxidation Disorders. Previous research suggests that triheptanoin may also be effective in the treatment PDC Deficiency. This study will investigate the saf...